drugset / Trial / NCT00354432
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Phase 3
Terminated
120 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
RandomizedFactorialQuadruple-blindSupportive care
Summary
RATIONALE: Soy protein/isoflavones and venlafaxine may help relieve hot flashes in patients receiving hormone therapy for prostate cancer. It is not yet known whether soy protein/isoflavones are more effective than venlafaxine when given together or with a placebo in treating hot flashes. PURPOSE: This randomized phase III trial is studying soy protein/isoflavones and venlafaxine to compare how well they work when given together or with a placebo in treating hot flashes in patients receiving hormone therapy for prostate cancer.
Timeline
- Start
- 2007-02-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Venlafaxine | Small molecule | 75 mg | Oral |